WHC is still in active development. Read this to understand our approach.
depiction of DYDCUQKUCUHJBH-UHFFFAOYSA-N.svg
isomerdesign

D-Cycloserine

Verificar en isomerdesign

pubchem

Cycloserine

Verificar en pubchem

drugmap

Cycloserine

Verificar en drugmap

Data

InChI: InChI=1S/C3H6N2O2/c4-2-1-7-5-3(2)6/h2H,1,4H2,(H,5,6)

Sinónimos: CYCLOSERINE (D),NSC756712,NSC 154851,SR-01000075432-9,CHEMBL771,Cycloserinum,CYCLOSERINE [WHO-IP],BIDD:GT0707,SBI-0050240.P004,SR-01000075432-5,SMP1_000167,Tebemicina,SPBio_000008,D-4-Amino-3-isossazolidone,SR-01000075432-10,Pharmakon1600-01500215,F2173-1228,SC-49088, Micoserina,NSC-154851,BPBio1_001252,3-Isoxazolidinone, 4-amino-, (R),IDI1_000098,Cycloserine, Pharmaceutical Secondary Standard; Certified Reference Material, (4R)-4-aminoisoxazolidin-3-one,SCHEMBL34322, Wasserina,NCGC00016306-07,Cycloserin, Seromycin, (+)-4-Amino-3-isoxazolidinone,NCGC00015213-02,KBio3_001341,NSC-76029,3-Isoxazolidinone, 4-amino-, d-,68-41-7,SPECTRUM1500215, Seromycin (TN),D-Cycloserine, >=96.0% (NT),MFCD00005353,D00877,4-Isoxazolidinamine, 3-oxo-, (D)-, PA 94,(R)-4-AMINO-ISOXAZOLIDIN-3-ONE,Spectrum5_000797,(R)-(+)-Cycloserine,SR-01000759389,ZINC34676245,Prestwick0_001089,(4R)-4-aminoisoxazolidin-3-one,DB00260,NCGC00015213-01,CCG-39705,Cicloserina,CYCLOSERINE [WHO-DD],NC00050, Cycloserin,Oxamycin,DTXSID8022870,(R)-4-AMINOISOXAZOLIDIN-3-ONE,ACT04767,SR-01000075432-2,D-Cycloserine, powder, Closina, C-9400, D-4-Amino-3-isossazolidone [Italian],CYCLOSERINE [JAN],NINDS_000098,Tox21_500252,C 3909,Prestwick3_001089,NCGC00016306-01,Prestwick2_001089,3-Isoxazolidinone, 4-amino-, (4R)-,.alpha.-Cycloserine, R(+)-4-Amino-3-isoxazolidinone,Cycloserine, D(+),CYCLOSERINE [USP MONOGRAPH], Oxamycin, Oxamicina [Italian],AKOS015994626, alpha-Cycloserine,D-Cycloserine synth. BP 88,Lopac-C-1159,HSDB 3218,cycloserine-(d), Alpha-Cycloserine,Cyclorin, (R)-4-Amino-Isoxazolidin-3-One,D-amino-3-isoxazolidinone,s1998,Tox21_110361_1,KBioGR_000890, Cicloserina [INN-Spanish],RO-1-9213,NCGC00093713-01, D-4-amino-3-isoxazolidinone,D-4-amino-3-isoxazolidone, FA6C7F8B-D080-4EA3-978F-1ECFB5A29D09,D-4-Amino-3-isossazolidone [Italian],R-(+)-Cycloserine,Tisomycin,Farmiserina, orientomycin,Novoserin,HMS2098I20, C-9390,HMS3260D06, cycloserine,MLS000758215,Cycloserine, United States Pharmacopeia (USP) Reference Standard, (R)-4-Amino-3-isoxazolidone,Cycloserinum [INN-Latin],DCS, Novoserin,UNII-95IK5KI84Z,AI3-50153,Wasserina, (R)-(+)-Cycloserine, Oxamicina, R-4-Amino-3-isoxazolidinone,SPBio_003029,C08057,CYCLOSERINE [HSDB], 68-41-7, I-1431,Closina,HMS2232F03,NCGC00016306-03,D-Cycloserine, synthetic,NSC-756712,EU-0100252,CYCLOSERINE [VANDF], D-CS,(+)-Cycloserine, R-(+)-Cycloserine,SR-01000759389-4,PA-94,CHEBI:40009,NCGC00016306-02,SR-01000075432-1,NJ-21,Prestwick1_001089,3-Isoxazolidinone, 4-amino-, (4R)- (9CI),BSPBio_001138,D-CS, (R)-Cycloserine,Q418508, PA-94, (+)-Cycloserine,(+)-4-Amino-3-isoxazolidinone,D-(+)-Cycloserine,Spectrum3_000371,(R)-(+)-4-Amino-3-isoxazolidinone,1pb9,EN300-97131, Farmiserina,HMS2051C15,DSSTox_GSID_22870,EINECS 200-688-4,KBio1_000098,D-cycloserine, D-(+)-Cycloserine, DRG-0195,Oxamicina [Italian],NCGC00016306-08,Cyclo-D-serine,Seromycin, Miroseryn, 3-Isoxazolidinone, 4-amino-, D,4-Amino-3-isoxazolidinone, (R)-, Cyclorin,Z1198154206,CAS-339-72-0, (R)-4-Amino-3-isoxazolidinone,AB00443920,NCGC00093713-02,NCGC00016306-04,NC00676,HS-0079,4AX,(R)-Cycloserine,3-Isoxazolidinone, 4-amino-, (R)-,CYCLOSERINE [INN],4-Amino-3-isoxazolidinone, D-,Cycloserine (JP17/USP/INN),(4R)-4-Amino-3-isoxazolidinone,D-Cycloserine,CYCLOSERINE [MART.],D-Oxamicina, (4R)-4-Amino-3-isoxazolidinone,C-9390,BDBM50038178, Miroserina,(4R)-4-azaniumyl-4,5-dihydroisoxazol-3-olate;(R)-4-AMINOISOXAZOLIDIN-3-ONE,Tox21_110361, E-733-A, 3-Isoxazolidinone, 4-amino-, (4R)-(9CI),DSSTox_CID_2870,Seromycin (TN),MLS002548887,NCGC00260937-01, Cycloserinum,AB00443920_09, D-Oxamycin,Micoserina,I-1431,005C353,CYCLOSERINE [MI],NCGC00015213-03,Oxamicina,NCGC00016306-05,Cicloserina [INN-Spanish],3-Isoxazolidinone, 4-amino-, D,Miroseryn,Cycloserine, D-,KBioSS_001340,Serine, cyclo-,AB00443920_10,K-300, Closerin,DivK1c_000098,FA6C7F8B-D080-4EA3-978F-1ECFB5A29D09,R(+)-4-Amino-3-isoxazolidinone,HMS3715I14,Spectrum4_000305,KBio2_001340,CYCLOSERINE [ORANGE BOOK], Cicloserina,(R)-4-Amino-3-isoxazolidinone,HMS1920C06,C-9400,Cicloserina [Italian],D-4-amino-3-isoxazolidinone, Cycloserine (JP15/USP/INN),(4R)-4-amino-1,2-oxazolidin-3-one,LMPK14000007, RO-1-9213,MLS001423962, K-300,Lopac0_000252,Lopac-C-7005,SR-01000075432, D-4-Amino-3-isossazolidone,(R)-4-Amino-3-isoxazolidone,SMR000058313, Cicloserina,alpha-Cycloserine,CYCLOSERINE [USP IMPURITY],D-Oxamycin,orientomycin,Closerin,KBio2_006476,Spectrum_000860, (R)-(+)-4-Amino-3-isoxazolidinone, (R)-4-AMINO-ISOXAZOLIDIN-3-ONE,BRN 0080798, Tisomycin,95IK5KI84Z,PA 94,HMS2091I14,AC-4721,NCGC00016306-17,cycloserine,4-27-00-05549 (Beilstein Handbook Reference),HMS500E20,HMS3259L19,(R)-3-Isoxazolidinone, 4-amino-,Lopac-C-3909, Cicloserina [Italian], Cyclo-D-serine, 3-Isoxazolidinone, 4-amino-, (R), Orientomycin,SDCCGSBI-0050240.P005,GTPL9489, SC-49088,A836140,DSSTox_RID_76766, 3-Isoxazolidinone, 4-amino-, (+)-(8CI),BSPBio_002121, Tebemicina, (4R)-4-amino-1,2-oxazolidin-3-one,Cycloserine [USP:INN:BAN:JAN], Cycloserinum [INN-Latin],DRG-0195,3-Isoxazolidinone, 4-amino-, (+)-,Spectrum2_000084,KBio2_003908,3-Isoxazolidinone, 4-amino-, (+)- (8CI), C 3909,CYCLOSERINUM [WHO-IP LATIN],CAS-68-41-7, D-4-amino-3-isoxazolidone, Cycloserine [INN:BAN:JAN], (R)-4-AMINOISOXAZOLIDIN-3-ONE,E-733-A,BDBM50103516, D-amino-3-isoxazolidinone,HMS1571I20,LP00252,Miroserina,HY-B0030

Estimated data

Solubilidad: 0.09 (log(S) in mol/L prediction using SolTranNet)

Blood Brain Barrier Permeability: Yes (prediction using frontiersin.org)

Addictivity Prediction: 55.3% (prediction based on www.mdpi.com)

Similitudes

The following is a set of comparisons to understand the properties of this compound. This is still higly experimental and is still under active development. Please refer to our series of blog posts to fully understand our approach and its limitations. This information is for informational purposes only and should not be construed as medical advice.